Cardio Diagnostics (CDIO) Competitors $0.24 -0.02 (-7.57%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends CDIO vs. SAI, TPST, GLYC, PIRS, COCP, MIRA, ENLV, PULM, CYTH, and SPRBShould you be buying Cardio Diagnostics stock or one of its competitors? The main competitors of Cardio Diagnostics include SAI.TECH Global (SAI), Tempest Therapeutics (TPST), GlycoMimetics (GLYC), Pieris Pharmaceuticals (PIRS), Cocrystal Pharma (COCP), MIRA Pharmaceuticals (MIRA), Enlivex Therapeutics (ENLV), Pulmatrix (PULM), Cyclo Therapeutics (CYTH), and Spruce Biosciences (SPRB). Cardio Diagnostics vs. SAI.TECH Global Tempest Therapeutics GlycoMimetics Pieris Pharmaceuticals Cocrystal Pharma MIRA Pharmaceuticals Enlivex Therapeutics Pulmatrix Cyclo Therapeutics Spruce Biosciences Cardio Diagnostics (NASDAQ:CDIO) and SAI.TECH Global (NASDAQ:SAI) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk, valuation and community ranking. Is CDIO or SAI more profitable? SAI.TECH Global has a net margin of 0.00% compared to Cardio Diagnostics' net margin of -22,777.20%. SAI.TECH Global's return on equity of 0.00% beat Cardio Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Cardio Diagnostics-22,777.20% -258.85% -191.20% SAI.TECH Global N/A N/A N/A Which has stronger earnings & valuation, CDIO or SAI? SAI.TECH Global has higher revenue and earnings than Cardio Diagnostics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCardio Diagnostics$20K311.10-$8.38MN/AN/ASAI.TECH Global$6.78M0.00-$6.12MN/AN/A Which has more volatility and risk, CDIO or SAI? Cardio Diagnostics has a beta of 4.73, meaning that its share price is 373% more volatile than the S&P 500. Comparatively, SAI.TECH Global has a beta of 1.83, meaning that its share price is 83% more volatile than the S&P 500. Do analysts prefer CDIO or SAI? Cardio Diagnostics presently has a consensus target price of $2.00, suggesting a potential upside of 669.53%. Given Cardio Diagnostics' stronger consensus rating and higher possible upside, analysts clearly believe Cardio Diagnostics is more favorable than SAI.TECH Global.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cardio Diagnostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00SAI.TECH Global 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals and insiders believe in CDIO or SAI? 8.1% of Cardio Diagnostics shares are held by institutional investors. Comparatively, 0.2% of SAI.TECH Global shares are held by institutional investors. 22.3% of Cardio Diagnostics shares are held by insiders. Comparatively, 1.4% of SAI.TECH Global shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media prefer CDIO or SAI? In the previous week, SAI.TECH Global had 1 more articles in the media than Cardio Diagnostics. MarketBeat recorded 1 mentions for SAI.TECH Global and 0 mentions for Cardio Diagnostics. SAI.TECH Global's average media sentiment score of 0.46 beat Cardio Diagnostics' score of -0.30 indicating that SAI.TECH Global is being referred to more favorably in the news media. Company Overall Sentiment Cardio Diagnostics Neutral SAI.TECH Global Neutral Does the MarketBeat Community prefer CDIO or SAI? Cardio Diagnostics received 4 more outperform votes than SAI.TECH Global when rated by MarketBeat users. CompanyUnderperformOutperformCardio DiagnosticsOutperform Votes480.00% Underperform Votes120.00% SAI.TECH GlobalN/AN/A SummaryCardio Diagnostics and SAI.TECH Global tied by winning 7 of the 14 factors compared between the two stocks. Ad Resource Stock DigestThe smart-money is buying this US$1 lithium stockLithium is getting white-hot once again! And that means well-timed investors who position now in the best names in the lithium space will be set for escalating gains in 2025 and beyond. It’s all being driven by the global EV boom as millions of drivers ditch their gasoline-chugging cars and trucks in favor of lithium-ion-powered vehicles in record numbers. Everything you need to know is in our FREE online lithium report you can get here. Get Cardio Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDIO vs. The Competition Export to ExcelMetricCardio DiagnosticsDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.22M$2.20B$5.00B$8.83BDividend YieldN/A0.72%5.18%4.07%P/E RatioN/A5.93131.3717.48Price / Sales311.1035.251,253.1599.42Price / CashN/A16.3433.2632.45Price / Book1.862.914.654.65Net Income-$8.38M$29.98M$118.24M$225.37M7 Day Performance-15.56%-6.94%-2.45%-2.13%1 Month Performance23.23%-13.13%-4.02%-0.20%1 Year Performance-88.24%-20.30%29.46%24.41% Cardio Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDIOCardio Diagnostics2.1246 of 5 stars$0.24-7.6%$2.00+719.0%-73.7%$5.85M$35,688.000.007Gap DownSAISAI.TECH GlobalN/AN/AN/AN/A$10.81M$6.78M0.0030TPSTTempest Therapeutics2.6791 of 5 stars$0.90+3.5%$20.00+2,126.2%-75.0%$22.65MN/A-0.5720Analyst RevisionGap UpGLYCGlycoMimetics3.7069 of 5 stars$0.33-13.2%$10.00+2,930.3%-73.9%$21.28M$10,000.000.0050Gap DownPIRSPieris Pharmaceuticals1.5381 of 5 stars$16.01+2.7%N/A-13.7%$21.13M$42.81M-1.29140Analyst UpgradeNews CoverageCOCPCocrystal Pharma3.3923 of 5 stars$2.06flat$7.00+239.8%+21.9%$20.96MN/A-1.1110News CoverageGap DownMIRAMIRA Pharmaceuticals2.4898 of 5 stars$1.27-9.6%$14.00+1,006.7%-57.8%$20.95MN/A-2.242Positive NewsENLVEnlivex Therapeutics3.1068 of 5 stars$0.98-5.2%$6.00+514.8%-40.8%$20.90MN/A-0.8770Gap UpHigh Trading VolumePULMPulmatrix0.2947 of 5 stars$5.62+3.5%N/A+199.2%$20.51M$7.30M-2.3020Analyst ForecastCYTHCyclo Therapeutics2.7731 of 5 stars$0.71+4.4%$0.95+34.0%-51.4%$20.39M$870,725.00-0.769News CoverageGap UpSPRBSpruce Biosciences3.4332 of 5 stars$0.49+0.9%$4.00+716.3%-64.0%$20.24M$7.10M-0.5220 Related Companies and Tools Related Companies SAI Competitors TPST Competitors GLYC Competitors PIRS Competitors COCP Competitors MIRA Competitors ENLV Competitors PULM Competitors CYTH Competitors SPRB Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CDIO) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Abandons USDExperts suggest we're on the brink of a major economic shift. Gold's value could soar when Trump brings bac...True Gold Republic | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredThe smart-money is buying this US$1 lithium stockLithium is getting white-hot once again! And that means well-timed investors who position now in the best n...Resource Stock Digest | SponsoredA huge crack is forming in the US economyFormer Trump Advisor Warning: “An Economic Rupture Is Coming” The legendary financier Brad Thomas served on...Wide Moat Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardio Diagnostics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardio Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDIO Stock Alerts